Corbus Pharmaceuticals Holdings (CRBP) EBIT Margin (2015 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) posted EBIT Margin of -6350.09% for FY2021, down 3230.88 percentage points from -3119.20% in FY2020.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) EBIT Margin (2015 - 2024) Analysis & Trends
Since FY2015, Corbus Pharmaceuticals Holdings has reported EBIT Margin for 6 years.
- Annual EBIT Margin shows a four-year change of -5015.65 percentage points (FY2017 to FY2021).
- The FY2021 figure stands as the lowest annual EBIT Margin in data going back to FY2015.
- Business Quant data shows CRBP's EBIT Margin at -3119.20% in FY2020 (-2905.88 pp), -213.33% in FY2019 (+963.45 pp), -1176.78% in FY2018 (+157.65 pp) and -1334.43% in FY2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 28.37% |
| 10 | Corbus Pharmaceuticals Holdings | 52.74 Mn | -463.89 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -1,304.04% |
| Jun 30, 2024 | -1,212.80% |
| Sep 30, 2023 | -4,357.53% |
| Jun 30, 2023 | -3,529.24% |
| Sep 30, 2021 | -14,257.07% |
| Jun 30, 2021 | -12,230.01% |
| Mar 31, 2021 | -2,379.38% |
| Dec 31, 2020 | -3,161.99% |
| Sep 30, 2020 | -2,760.72% |
| Jun 30, 2020 | -13,319.09% |
| Mar 31, 2020 | -1,696.04% |
| Dec 31, 2019 | -1,056.54% |
| Sep 30, 2019 | -969.07% |
| Jun 30, 2019 | 5.86% |
| Mar 31, 2019 | -1,406.53% |
| Dec 31, 2018 | -912.72% |
| Sep 30, 2018 | -1,365.69% |
| Jun 30, 2018 | -1,451.86% |
| Mar 31, 2018 | -1,248.36% |
| Sep 30, 2017 | -873.63% |
API Access
Corbus Pharmaceuticals Holdings EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();